Lamotrigine Tablet, For Suspension
Product Images NDC 46708-095

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 46708-095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 mg 30's Bottle Pack (Lamotrigine 10mg)

This is a medication description of a drug called "Lamotrigine Tablets". It contains 25mg of "amotgne USP" and "Pheny'aanine 0.98mg per tablet". It comes in a container that is tough enough for safe storage. The tablets can be swallowed whole, chewed, or dispersed in water or juice. The dosage and administration instructions can be found in the package insert. The drug was manufactured by Alembic Pharmaceuticals Limited in Gujarat, India. It is dispensed with a medication guide and is available only by prescription. The medication complies with Organic Impurities Procedure I. The Lot and EXP numbers are not available.*

FDA Label Image

5 mg 30's Bottle Pack (Lamotrigine 5mg)

FDA Label Image

Figure 1 (Lamotrigine Figure1)

FDA Label Image

Figure 2 (Lamotrigine Figure2)

This text does not provide enough information for a useful description. "Fallure Probabilty (%)" and "Lamotrigine" are not coherent, and the rest of the text is not available.*

FDA Label Image

Structure (Lamotrigine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.